The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Prevalence of high tumor mutational burden (TMB-H) and microsatellite instability-high (MSI-H) status in neuroendocrine neoplasms.
 
Sukhmani Kaur Padda
Honoraria - CME Solutions; Janssen; Jazz Pharmaceuticals; MECC Global Meetings; Medical Oncology Association of Southern California; Nanobiotix; Physicans' Education Resource
Consulting or Advisory Role - AstraZeneca; AstraZeneca; Blueprint Medicines; G1 Therapeutics; Genentech; Genzyme; Janssen Oncology; Jazz Pharmaceuticals; Mirati Therapeutics
Research Funding - Bayer (Inst); BioAtla (Inst); Boehringer Ingelheim (Inst); EpicentRx (Inst)
Other Relationship - OncLive/MJH Life Sciences
 
Rahul Raj Aggarwal
Honoraria - Clovis Oncology
Consulting or Advisory Role - Advanced Accelerator Applications; Alessa Therapeutics; Alessa Therapeutics; Amgen; AstraZeneca; Axiom Biotechnologies; Clovis Oncology; Dendreon; Jubilant Pharmaceuticals; Merck; Pfizer
Research Funding - Abbvie (Inst); Amgen (Inst); AstraZeneca (Inst); BioXCel therapeutics (Inst); Cancer Targeted Technology (Inst); Janssen (Inst); Merck (Inst); Novartis (Inst); Xynomic Pharma (Inst); Zenith Epigenetics (Inst)
 
Arya Ashok
Employment - Tempus
Stock and Other Ownership Interests - Tempus
Travel, Accommodations, Expenses - Tempus
 
Elizabeth Mauer
Employment - Tempus
Stock and Other Ownership Interests - Tempus
Research Funding - Tempus
Travel, Accommodations, Expenses - Tempus
 
Maryam Shirazi
Employment - Tempus
Stock and Other Ownership Interests - Tempus
 
Emily K. Bergsland
Stock and Other Ownership Interests - exai bio (I); More Health (I)
Consulting or Advisory Role - More Health (I)
Research Funding - Merck
Patents, Royalties, Other Intellectual Property - UpToDate
(OPTIONAL) Uncompensated Relationships - Amgen